Evaluation of the endometrial receptivity assay and the preimplantation genetic test for aneuploidy in overcoming recurrent implantation failure.

Mauro CozzolinoPatricia Diaz-GimenoAntonio PellicerNicolas Garrido

Published in: Journal of assisted reproduction and genetics (2020)

PGT-A may be beneficial for patients with moderate recurrent implantation failure but not for severe cases. At its current level of development, ERA does not appear to be clinically useful for patients with RIF.

Keyphrases

high throughput
early onset
high intensity
endometrial cancer
copy number
drug induced